Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Crigler-Najjar syndrome type 1 (CN-1) is a severe genetic disorder causing unconjugated hyperbilirubinemia due to bilirubin-UDP-glucuronosyltransferase deficiency.
• Previously, CN-1 was linked to mutations within the coding exons of the UGT1A1 gene, affecting the bilirubin-UGT1 enzyme.
• Understanding the genetic basis of CN-1 is crucial for potential therapeutic strategies.

Observation:

• Two CN-1 patients presented with mutations in the noncoding intronic regions of the UGT1A1 gene, deviating from previously identified exon mutations.
• Patient A had a homozygous splice-donor site mutation in intron 1, while Patient B was heterozygous for a splice-acceptor site mutation in intron 3, with an additional exon mutation.
• These intronic mutations were investigated by expressing amplified genomic DNA splice junctions in COS-7 cells to analyze mRNA structure.

Findings:

• Intronic mutations in the UGT1A1 gene were identified as a cause of CN-1 in the studied patients.
• Splice-site mutations resulted in the utilization of cryptic splice sites, leading to deletions in the processed bilirubin-UGT1 mRNA.
• This is the first report demonstrating intronic mutations causing CN-1 and detailing their impact on mRNA structure through ex vivo expression.

Implications:

• This research expands the known spectrum of UGT1A1 mutations associated with Crigler-Najjar syndrome type 1.
• The findings highlight the importance of intronic regions in gene function and disease pathogenesis.
• The ex vivo expression system provides a valuable method for studying the functional consequences of splice-site mutations in genetic disorders.